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SURGICAL TREATMENT OF 
PATIENTS WITH WOLFF- 
PARKINSON-WHITE 
SYNDROME AND 
ASSOCIATED EBSTEIN'S 
ANOMALY 
Ebstein's anomaly is the most common congenital heart disease associated 
with the Wolff:Parkinson-White syndrome. Between November 1973 and 
March 1993, we surgically treated 42 patients with Wolff-Parkinson-White 
syndrome and Ebstein's anomaly. The patients' ages ranged from 5 months 
to 59 years (mean 35.3 +- 14.0 years). There were a total of 52 accessory 
pathways, 48 of which were located in the right (65%) or posteroseptai 
(29%) area. A left-sided accessory pathway was seen in only two patients 
(3.8%). Division of all right-sided accessory pathways was done during 
normothermic ardiopulmonary bypass with the heart beating; cryocoagu- 
lation was applied together with scalpel dissection of the atrioventricular 
groove. Division of the left-sided accessory pathways was done with the use 
of cold potassium cardioplegie arrest. Thirty-five of these patients under- 
went tricuspid valve operation for Ebstein's anomaly and 11 of them 
underwent ricuspid valve replacement with a bioprosthesis. All 52 acces- 
sory pathways were successfully divided, although two patients required 
reoperation because of tachycardia caused by accessory pathways in 
different positions. Three hospital deaths (7.1%) occurred. There were no 
late deaths during the follow-up period (mean 94.3 - 52.4 months), but two 
patients required repeat tricuspid operation because of progression of the 
tricuspid regurgitation. Because no repeat operations were required during 
long-term follow-up in patients who underwent valve repair or valve 
replacement, correction should be indicated in some patients. (J THORAC 
CARDIOVASC SURG 1995;110:1702-7) 
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E bstein's anomaly is the most common congenital cardiac anomaly associated with Wolff=Parkin- 
son-White (WPW) syndrome. 1 The clinical course 
{ . 
in patients with this combination is diverse and 
depends on the degree of severity of Ebstein's 
anomaly and associated arrhythmias. 2 Concerning 
this pathologic ombination 3-9 there have been sev- 
eral electrophysiol0gic and surgical reports includ- 
ing those by Danielson and colleagues 1°and Press- 
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ley and colleagues, 11but the long-term results of 
surgical treatment for this combination remain un- 
clear. The purpose of this study was to evaluate the 
surgical treatment in 42 patients who were followed 
up for up to 20 years tO extend our initial observa- 
tions regarding this combination. 12
Patients and methods 
Between November 1973 and March 1993, 455 patients 
underwent surgical division of the accessory pathway 
(ACP) for treatment of WPW syndrome at our institutes 
(Kanazawa University School of Medicine and Toyama 
Medical and Pharmaceutical University); Of these pa- 
tients, 42 had associated Ebstein's anomaly. The patients' 
ages ranged from 5 months to 59 years (mean 35.3 +- 14.0 
years). The findings in these 42 patients were compared 
with thoSe in the 413 patients without Ebstein's anomaly. 
The type and history of arrhythmias and number and 
location of ACPs, as well as the effective refractory period 
of antegrade ACPs, cycle length of reentrant tachycardias, 
and the shortest R-R interval during atrial fibrillation, 
were routinely examined (Table I). Fourteen patients 
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Table I. Patient characteristics and electrophysiologic features 
Ebstein's anomaly 
Present(n = 42) Absent (n = 413) p Value 
Mean age at operation (yr) 35.3 -+ 14.0 37.5 _+ 16.0 
Duration of arrhythmia (yr) 15.5 -+ 12.1 12.4 _+ 10.7 
History of cardiac arrest 3 (7.1%) 11 (2.7%) 
History of direct cardioversion 17 (40%) 127 (31%) 
Documented AF 24 (57%) 222 (54%) 
Postoperative AF 2 (5.2%) 42 (10%) 
Documented AVRT 38 (91%) 357 (87%) 
Shortest R-R interval during AF (msec) 216 _+ 42 227 _+ 51 
ERP of antegrade ACP (msec) 284 _+ 37 276 _+ 42 
Mean cycle length during AVRT (msec) 344 _+ 58 330 _+ 57 
Multiple pathways 10 (24%) 35 (8.5%) 
Total number of ACPs 52 451 
Location of ACP 
Left 2 (3.8%) 267 (59%) 
Posteroseptal 15 (29%) 48 (11%) 
Right 33 (63%) 124 (27%) 
Anteroseptal 2 (3.8%) 12 (2.7%) 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
<0.01 
<0.01 
<0.01 
<0.01 
NS 
AF, Atrial fibrillation; AVRT, atrioventricular tachycardia; ERP. effective r fractory period. 
(33 %) with mild Ebstein's anomalies had New York Heart 
Association (NYHA) functional class I or II symptoms. In 
12 of these patients, the Ebstein's anomaly was not 
suspected by the physicians who referred the patients to us 
and mild anomaly was diagnosed in our institution during 
the preoperative echocardiographic assessment. Twenty- 
eight patients (67%) had moderate to severe Ebstein's 
anomaly with NYHA class III or IV symptoms and all of 
them had moderate or severe tricuspid regurgitation. 
Surgical technique. After a median sternotomy, epicar- 
dial mapping was done to estimate the location of the 
ACP. 13 Division of all right-sided ACPs, including those 
in the posterior septum, was done during normothermic 
cardiopulmonary b pass with the heart beating. Before a 
right atriotomy was done, the heart was briefly fibrillated 
to obtain closure of a patent foramen ovale or an atrial 
septal defect. The heart was then defibrillated, and a 
supraannular trial incision was made 2 mm above the 
true anulus of the tricuspid valve. The supraannular trial 
incisions for the right posterior or posteroseptal ACPs 
were extended from the coronary sinus to the anteroinfe- 
rior commisure of the tricuspid valve. Dissection was done 
between the underlying fat tissue and the ventricular 
muscle. Closure of the atrial incision, tricuspid valvular 
operation, and division of left-sided ACPs were done with 
the use of cold potassium cardioplegic arrest. 
Of the 35 patients who underwent ricuspid valve 
operation for Ebstein's anomaly (Table II), 24 underwent 
Hardy's procedure: tricuspid valve repair and plications of 
atrialized right ventricles. 9' 14 The other 11 patients un- 
derwent tricuspid valve replacements; a Hancock porcine 
bioprosthesis* was used in five patients and a Carpentier- 
Edwards bioprosthesist in six. Warfarin anticoagulation 
was initiated after removal of the chest ube. All patients 
*Johnson & Johnson Cardiovascular, King of Prussia, Pa. 
tBaxter Healthcare Corp., Edwards Division, Santa Ana, Calif. 
Table II. Surgical procedures (n = 42) 
No. 
Division of accessory pathway 42 
Repeat ACP division 2 
Tricuspid valve operation 35 
Hardy's procedure* 24 
Tricuspid valve replacement 11 
Additional procedure 19 
Closure of ASD 10 
Closure of PFO 8 
Replacement ofascending 1 
aorta and aortic valve replacement 
ASD, Atrial septal defect; PFO, persistent foramen ovaIe. 
*Tricuspid valve repair with plication of atrialized right ventricle. 
received warfarin for up to 3 months after implantation 
and thereafter it was discontinued. 
Other associated cardiovascular bnormalities were ob- 
served in 19 patients, and those were corrected simulta- 
neously. The procedures included 10 closures of secon- 
dum-type atrial septal defect, 8 closures of patent foramen 
ovale, and one replacement of the aortic valve and 
ascending aorta. 15 
Patient follow-up was done by maintaining direct con- 
tact with them or with their physicians. Follow-up was 
available for all patients, resulting in a 100% rate of 
completion. 
Statistical methods. Data are expressed as mean plus 
or minus standard eviation. Univariate analysis was done 
with Student's t test and X 2 test was used for comparison 
between groups. The probability of various factors influ- 
encing coexistence of Ebstein's anomaly was assessed by 
logistic regression analysis Actuarial curves for event-free 
survival and death were generated by the method of 
Kaplan and Meier. The influence of various factors on risk 
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Table IlL Results of logistic regression a alysis for coexistence of Ebstein's anomaly 
95% Confidence limits 
Variables Odds ratio Lower Upper p Value 
AVRT 1.560 0.497 4.895 0.46 
Duration of arrhythmia 1.034 1.005 1.064 0.02 
History of cardiac arrest 3.095 0.719 13.326 0.13 
History of DC 1.319 0.641 2.715 0.45 
No. of ACPs 2.264 1.105 4.639 0.03 
AVRT, Atrioventricular t chycardia; DC, direct cardioversion. 
of mortality was assessed by the Cox proportional hazards 
model. Odds ratios were quoted with 95% confidence 
intervals, with statistical significance at at least the5% 
level being inferred. 
Results 
Clinical electrophysiologic characteristics. There 
was no significant difference in the clinical and 
electrophysiologic characteristics between the pa- 
tients with and without Ebstein's anomaly (Table I).
ACP distribution is also shown in this table. In the 
group of patients with Ebstein's anomaly, 10 pa- 
tients (24%) had multiple pathways. Of 52 ACPs, 48 
were located in the right (65%) or right posterosep- 
tal (29%) area, whereas left-sided, right lateral, or 
right anteroseptal ACPs were seen in only two 
patients (3.8%). In patients without Ebstein's anom- 
aly the most common location of ACPs was the left 
side. The difference in these distribution patterns 
between the patient groups was statistically signifi- 
cant. 
Multivariate logistic analysis demonstrated that 
the odds ratios of two factors, duration of arrhyth- 
mia and number of ACPs, were significant, suggest- 
ing their relevance to Ebstein's anomaly associated 
with WPW syndrome (Table III). 
Early surgical results. In the patients with Eb- 
stein's anomaly, three hospital deaths (7.1%) oc- 
curred. The cause of death in two patients, 40 and 57 
years old, respectively, with preoperative NYHA 
class IV symptoms, was low cardiac output after 
division of ACPs and tricuspid valve replacement. 
The remaining death occurred in a 38-year-old 
woman with a history of open cardiac massage 
necessitated bycardiac arrest. She died 22 days after 
tricuspid valve replacement of occult cancer (his- 
tiocytoma) refractory to chemotherapy. In these 
three patients, both delta waves and atrioventricular 
reentrant achycardia had disappeared postopera- 
tively. 
Late surgical results. All of the remaining pa- 
tients were followed up. No late deaths occurred 
during the mean follow-up interval (mean 94.3 +_ 
52.4 months). During this period, four patients 
required a repeat cardiac operation. In two patients, 
reoperations were done because of recurrence of 
tachycardia caused by residual second ACPs 6 years 
and 4 months and 5 years and 1 month, respectively, 
after initial division of the ACPs. These ACPs were 
located in a different position from the initial ACPs. 
In one of the patients, plication was done because of 
mild tricuspid regurgitation in addition to second 
ACP division. Another patient, who initially had 
mild preoperative tricuspid regurgitation, required a
tricuspid valve replacement 1 year and 7 months 
after the initial operation because of severe hy- 
poproteinemia caused by progressive tricuspid re- 
gurgitation. The remaining patient required aortic 
valve replacement because of infective ndocarditis 
5 years and 1 month after the initial operation. 
Eleven patients underwent ricuspid valve re- 
placement with a xenograft because of tricuspid 
valve insufficiency caused by severe Ebstein's anom- 
aly. During the follow-up period (mean 93.4 + 59.4 
months), no valve dysfunction, bleeding complica- 
tion, or thromboembolic complication was noted 
and no reoperations were done. 
Although two patients required reoperation be- 
cause of tachycardia, fter operation o recurrence 
of reentrant tachycardia was observed in any of the 
39 patients. The postoperative prevalence of atrial 
fibrillation (5.1%, 2/39) was significantly decreased 
compared with the preoperative incidence (55%, 
23/42). There were no patients with new atrial 
fibrillation. All 39 patients were free from the need 
for antiarrhythmic drugs and had functional class I 
or II symptoms at the time of the most recent 
follow-up. 
Results of Kaplan-Meier analysis of overall sur- 
vival probability in patients with and without Eb- 
stein's anomaly from the time of operation are 
shown in Fig. 1. Factors that influenced overall 
mortality are shown in Table IV. Multivariate Cox 
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FJig. 1. Results of Kaplan-Meier analysis of overall survival probability from time of operation. 
Table IV. Results of Cox regression analysis for factors predictive of overall mortality 
Variables Odds ratio 
95% Confidence limits 
Lower Upper p Value 
Age 0.992 0.952 1.034 0.70 
Combined isease 0.254 0.024 2.656 0.25 
AVRT 2.739 0.296 25.331 0.38 
AF 1.869 0.387 9.021 0.44 
History of cardiac arrest 2.656 0.268 26.294 0.40 
History of DC 1.247 0.322 4.831 0.75 
No. of ACPs 1.964 0.494 7.806 0.34 
Combined operation 6.866 1.650 28.569 0.01 
AVRT, Atrioventricular t chycardia; AF, atrial fibrillation; DC, direct cardioversion. 
analysis demonstrated that combined operation was 
a significant predictor of death. 
Discussion 
Location of ACPs. In this study, we documented 
the electrophysiologic characteristics of ACPs in 
patients with Ebstein's anomaly. In our patients, 
92% (48/52) of ACPs were located on the right side 
or in the posteroseptal rea. This finding is consis- 
tent with the hypothesis that Ebstein's anomaly 
originates from the incomplete separation of the 
right atrium and right ventricle during cardiogen- 
esis. 16 Therefore it is possible that any part of the 
atrialized ventricle can be connected to the right 
atrium across the true anulus. This predominance of 
right posterior and right posteroseptal ACPs in 
patients with Ebstein's anomaly has been previously 
reported by us 15 and Smith and associates. 8 This 
finding may have clinical implications in terms of the 
selection of the surgical procedure. We performed 
complete detachment of the atrialized ventricle with 
use of a relatively large incision along the true 
anulus,  
Multiple ACPs. In 1980 we reported a case of 
successful simultaneous operation for WPW syn- 
drome in a patient with multiple ACPs and tricuspid 
valve replacement] We observed multiple ACPs in 
24% of the patients with Ebstein's anomaly, which 
was more frequent than i patients without Eb- 
stein's anomaly. A high prevalence ofmultiple ACPs 
is another electrophysiologic characteristic of this 
combination. In the patients of Pressley and associ- 
ates, 1~ multiple ACPs were observed at a much 
higher ate (50%) than in our patients. In our series, 
left-sided ACP was observed in two patients and 
accompanied one of the cases of multiple ACPs. 
Left-sided ACP is quite rare in patients with Eb- 
stein's anomaly. 11' 17 
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Atrial fibrillation. The propensity for atrial fibril- 
lation is suspected to be increased in patients with 
combined heart disease. 15 However, in our series 
there was no significant difference between patients 
with and without Ebstein's anomaly in the percent- 
age of atrial fibrillation or the shortest preexcited 
R-R interval during atrial fibrillation. It is believed 
that these features may reflect he inclusion of patients 
at high risk with atrial fibrillation in this study. It is 
suggested that some degenerative changes of the 
atrium may be present in patients with Ebstein's 
anomaly. These observations are in accordance with 
the results described in the previous reportJ 1 
Mild Ebstein's anomaly and sudden cardiac ar- 
rest. Three of our patients had histories of sudden 
cardiac arrest. However, this rate was not signifi- 
cantly different from that in the patients without 
Ebstein's anomaly who underwent operation for 
WPW. Two of the patients with histories of sudden 
cardiac arrest had associated mild Ebstein's anom- 
aly that did not necessitate any additional operation. 
Rossi and Thiene Is have reported similar cases of 
mild Ebstein's anomaly associated with sudden car- 
diac arrest. None of our patients with mild Ebstein's 
anomaly had significant hemodynamic alterations 
during sinus rhythm attributable to the malforma- 
tion itself. Therefore, when nonpharmacologic pro- 
cedures for this life-threatening arrhythmia are 
done it should be taken into consideration that 
patients with mild Ebstein's anomaly are at risk for 
the same severe arrhythmogenic events as patients 
with the classic forms of Ebstein's anomaly. Because 
unusual progression of tricuspid regurgitation was 
observed in three patients, a potential risk of reop- 
eration was suggested. 
Early mortality. In our patients, the surgical mor- 
tality rate was 7.1% (3/42). This indicates that a 
result comparable to that for patients with Ebstein's 
anomaly (5.3% to 25%) l°' 21, 19 was safely achieved 
in patients with Ebstein's anomaly associated with 
WPW syndrome. All three of the patients who died 
were in a relatively high age group (mean age 45 
years), required tricuspid valve replacement, and 
had severely deteriorated preoperative cardiac func- 
tion (NYHA class IV). The cause of death was 
thought o have been related not to the division of 
ACPs, but rather to the severity of the Ebstein's 
anomaly itself. These data suggest that early surgical 
intervention should be considered for patients with 
severe Ebstein's anomaly. 
Long-term survival nd morbidity. Excellent long- 
term results were obtained in our patients. The late 
mortality rate after operation for patients with Eb- 
stein's anomaly has been reported to range from 
5.6% to 15%. 1°' 11, 19 The causes of death in these 
patients were sudden death and uncontrolled ar- 
rhythmias. As stated, two of our patients required 
repeat ricuspid valve operation because of progres- 
sion of tricuspid insufficiency caused by Ebstein's 
anomaly. Because no repeat operation has been 
required uring long-term follow-up in patients who 
underwent tricuspid valve repair or valve replace- 
ment at operation, correction of tricuspid regurgita- 
tion might be indicated in some patients. Currently, 
such patients might be treated by catheter ablation 
and followed up carefully for possible progression of 
tricuspid regurgitation. 
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